ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

April 28, 2006

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

In Brief: Baltimore Names President, Caltech; Watson, Weinberg, Win National Medals of Science

May 16, 1997

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992

HHS Plan Ties Breast Screening; Mammography Quality

July 16, 1993